CDK2 and cancer: In addition, CDK2 positively regulates HIF-1α transactivity in cancer cells, and it was postulated that CDK2 could uncouple the transcriptional and non-transcriptional functions of HIF-1α in a manner analogous to the well-characterised mechanism involving cMYC and SKP2 [58,60].